B-LYMPHOCYTE COUNT DECREASED side effect
What is B-LYMPHOCYTE COUNT DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
B-LYMPHOCYTE COUNT DECREASED and Recently Reported Side Effects
B-LYMPHOCYTE COUNT DECREASED and 15 most Active Side Effect polls
B-LYMPHOCYTE COUNT DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with B-LYMPHOCYTE COUNT DECREASED
CARBIDOPA CYCLOPHOSPHAMIDE HUMIRA MABTHERA METHOTREXATE PROGRAF RITUXAN TEGRETOLCarbidopa Side Effects Report #5648442-0
Physician from JAPAN reported CARBIDOPA AND LEVODOPA problem on Feb 25, 2008. Male patient, 78 years of age, was diagnosed with skin disorder, parkinson's disease and was treated with CARBIDOPA AND LEVODOPA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, carotid artery stenosis, cerebral infarction, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, hemiparesis, hypoaesthesia, neutrophil count abnormal, . CARBIDOPA AND LEVODOPA dosage: 300 MG. During the same period patient was treated with PANTOSIN, KAMAG G, TAMSULOSIN, UBRETID, FAMOTIDINE, PREDONINE, COMTAN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5664852-X
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
Carbidopa Side Effects Report #5634548-9
Physician from JAPAN reported CARBIDOPA AND LEVODOPA problem on Feb 15, 2008. Male patient, 78 years of age, was diagnosed with skin disorder, parkinson's disease and was treated with CARBIDOPA AND LEVODOPA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, carotid artery stenosis, cerebral infarction, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, hemiparesis, neutrophil count abnormal, red blood cell count decreased, . CARBIDOPA AND LEVODOPA dosage: 300 MG. During the same period patient was treated with PANTOSIN, KAMAG G, TAMSULOSIN, UBRETID, FAMOTIDINE, PREDONINE, COMTAN. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5579736-5
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 27, 2007. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
Cyclophosphamide Side Effects Report #5479878-9
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Oct 01, 2007. Female patient, 52 years of age, was diagnosed with rheumatoid arthritis, psoriasis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, psoriasis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with RITUXIMAB, TOPICAL STEROIDS. Patient recovered.
Cyclophosphamide Side Effects Report #5479879-0
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Oct 01, 2007. Female patient, 25 years of age, was diagnosed with rheumatoid arthritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, onycholysis, psoriasis, tendon rupture, uveitis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, SULFASALAZINE, CYCLOSPORINE, RITUXIMAB, METHYLPREDNISOLONE. Patient recovered.
Cyclophosphamide Side Effects Report #5479880-7
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Oct 01, 2007. Female patient, 26 years of age, was diagnosed with systemic lupus erythematosus and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, cerebral haemorrhage, onycholysis, psoriasis, thrombocytopenia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with RITUXIMAB, DMARDS, STEROIDS, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5429774-8
RITUXAN problem was reported by a Physician from UNITED KINGDOM on Aug 20, 2007. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
Methotrexate Side Effects Report #5373458-1
Health Professional from AUSTRALIA reported METHOTREXATE problem on June 25, 2007. Male patient, child 8 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, hair growth abnormal, hypogammaglobulinaemia, rash, respiratory tract infection viral, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, IDARUBICIN, ASPARAGINASE, CYTARABINE, DEXAMETHASONE, MERCAPTOPURINE. Patient recovered.
Mabthera Side Effects Report #5273352-0
MABTHERA problem was reported by a Physician from GERMANY on Mar 09, 2007. Male patient, 75 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, coma, dyspnoea, t-lymphocyte count decreased, . MABTHERA dosage: unknown. Patient recovered.
Mabthera Side Effects Report #5280406-1
Physician from SWEDEN reported MABTHERA problem on Mar 10, 2007. Female patient, child 1 years of age, was diagnosed with vasculitis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, cognitive disorder, diplopia, jc virus infection, leg amputation, progressive multifocal leukoencephalopathy, . MABTHERA dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Humira Side Effects Report #5611623-6
HUMIRA problem was reported by a Physician from SPAIN on Jan 24, 2008. Male patient, weighting 20.90 lb, was diagnosed with juvenile arthritis, hypertension, prophylaxis, constipation and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, b-lymphocyte count decreased, bone marrow failure, constipation, cytomegalovirus infection, dyspnoea, haematuria, hepatosplenomegaly, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, AMLODIPINE BESYLATE, BACTRIM, MACROGOL. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5589560-5
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on Jan 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, b-lymphocyte count decreased, disease recurrence, herpes zoster, intestinal obstruction, pneumonia aspiration, post procedural pneumonia, progressive multifocal leukoencephalopathy, respiratory failure, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
Methotrexate Side Effects Report #5379846-1
METHOTREXATE problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, child 8 years of age, was diagnosed with t-cell type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: alopecia, b-lymphocyte count decreased, humoral immune defect, hypogammaglobulinaemia, lower respiratory tract infection, madarosis, rash papulosquamous, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, MERCAPTOPURINE. Patient recovered.
Prograf Side Effects Report #5403457-2
Physician from JAPAN reported PROGRAF problem on July 13, 2007. Female patient, 47 years of age, was diagnosed with renal transplant, kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, b-lymphocyte count decreased, cytomegalovirus infection, dialysis, hypogammaglobulinaemia, kidney transplant rejection, myeloid maturation arrest, no therapeutic response, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
Methotrexate Side Effects Report #5379846-1
METHOTREXATE problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, child 8 years of age, was diagnosed with t-cell type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: alopecia, b-lymphocyte count decreased, humoral immune defect, hypogammaglobulinaemia, lower respiratory tract infection, madarosis, rash papulosquamous, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, MERCAPTOPURINE. Patient recovered.
Prograf Side Effects Report #5403457-2
Physician from JAPAN reported PROGRAF problem on July 13, 2007. Female patient, 47 years of age, was diagnosed with renal transplant, kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, b-lymphocyte count decreased, cytomegalovirus infection, dialysis, hypogammaglobulinaemia, kidney transplant rejection, myeloid maturation arrest, no therapeutic response, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
Tegretol Side Effects Report #5683943-0
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 25, 2008. Female patient, child 8 years of age, was diagnosed with convulsion, gastric ulcer, vitamin supplementation and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-lymphocyte count decreased, blood alkaline phosphatase increased, granulocytopenia, hepatic function abnormal, hypogammaglobulinaemia, . TEGRETOL dosage: 120 MG/DAY. During the same period patient was treated with ALEVIATIN, SELENICA, MYSTAN, PHENOBAL, TAKEPRON, PANCAL, ZONISAMIDE, URSO. Patient recovered.
Tegretol Side Effects Report #5636359-7
Consumer or non-health professional from JAPAN reported TEGRETOL problem on Feb 19, 2008. Female patient, child 8 years of age, was diagnosed with convulsion, gastric ulcer, vitamin supplementation and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-lymphocyte count decreased, blood alkaline phosphatase increased, granulocytopenia, hepatic function abnormal, hypogammaglobulinaemia, pyrexia, . TEGRETOL dosage: 120 MG/DAY. During the same period patient was treated with ALEVIATIN, SELENICA, MYSTAN, PHENOBAL, LANSOPRAZOLE, PANCAL, ZONISAMIDE, URSO. Patient was hospitalized. Patient recovered.